These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37558164)

  • 1. Management of Pregnancies Alloimmunized with Non-Rh and Non-K Alloantibodies.
    Jackson ME; Grabowska K; Lieberman L; Clarke G; Yan MTS;
    J Obstet Gynaecol Can; 2024 Jan; 46(1):102189. PubMed ID: 37558164
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter to the Editor: Management of Pregnancies Alloimmunized with Non-Rh and Non-K Alloantibodies.
    Jackson ME; Grabowska K; Lieberman L; Clarke G; Yan MTS;
    J Obstet Gynaecol Can; 2024 Mar; 46(3):102299. PubMed ID: 38548447
    [No Abstract]   [Full Text] [Related]  

  • 3. Oliver memorial lecture. Towards the conquest of Rh haemolytic disease: Britain's contribution and the role of serendipity.
    Tovey LA
    Transfus Med; 1992 Jun; 2(2):99-109. PubMed ID: 1339195
    [No Abstract]   [Full Text] [Related]  

  • 4. Predicting Intrauterine Transfusion Interval and Perinatal Outcomes in Alloimmunized Pregnancies: Time-to-Event Survival Analysis.
    Snelgrove JW; D'Souza R; Seaward PGR; Windrim R; Kelly EN; Ryan G
    Fetal Diagn Ther; 2019; 46(6):425-432. PubMed ID: 31195389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Blood group immunization: results of treatment of fetal anemia with intra-uterine intravascular blood transfusion in the Netherlands, 1987-1995].
    van Kamp IL; Klumper FJ; Meerman RH; Brand A; Bennebroek Gravenhorst J; Kanhai HH
    Ned Tijdschr Geneeskd; 1999 Dec; 143(50):2527-31. PubMed ID: 10627756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Maternal blood intrauterine transfusions in the therapy of red-cell alloimmunization performed in three difficult cases].
    Kucińska-Chahwan A; Massalska D; Bijok J; Rudzińska M; Kopeć I; Rzymkiewicz L; Jakiel G; Roszkowski T
    Ginekol Pol; 2014 Sep; 85(9):703-7. PubMed ID: 25322544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The severity of immune fetal hydrops is predictive of fetal outcome after intrauterine treatment.
    van Kamp IL; Klumper FJ; Bakkum RS; Oepkes D; Meerman RH; Scherjon SA; Kanhai HH
    Am J Obstet Gynecol; 2001 Sep; 185(3):668-73. PubMed ID: 11568796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment options for the fetus with alloimmune hemolytic disease.
    Bowman JM
    Transfus Med Rev; 1990 Jul; 4(3):191-207. PubMed ID: 2134630
    [No Abstract]   [Full Text] [Related]  

  • 9. Fetal transfusion.
    Queenan JT
    Fetal Ther; 1986; 1(1):59-64. PubMed ID: 3145669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systems of life. Blood: 5.
    Roberts A
    Nurs Times; 1994 Oct 12-18; 90(41):39-42. PubMed ID: 7971374
    [No Abstract]   [Full Text] [Related]  

  • 11. [Specificity and incidence of erythrocyte antibodies in pregnant patients with intrauterine transfusions for fetal erythroblastosis].
    Hoch H; Giers G; Bald R; Hanfland P
    Beitr Infusionsther; 1992; 30():439-42. PubMed ID: 1284755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perinatal survival following intrauterine transfusion for red cell alloimmunized pregnancies: systematic review and meta-regression.
    Donepudi RV; Javinani A; Mostafaei S; Habich A; Miller J; Chmait RH; Shamshirsaz AA
    Am J Obstet Gynecol; 2024 Mar; 230(3):e1-e2. PubMed ID: 37839589
    [No Abstract]   [Full Text] [Related]  

  • 13. [Management of feto-maternal red cell allo-immunizations].
    Bricca P; Guinchard E; Guitton Bliem C
    Transfus Clin Biol; 2011 Apr; 18(2):269-76. PubMed ID: 21397546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concerning "Management of Pregnancies Alloimmunized with Non-Rh and Non-K Alloantibodies".
    Somerset D
    J Obstet Gynaecol Can; 2024 Mar; 46(3):102300. PubMed ID: 38548451
    [No Abstract]   [Full Text] [Related]  

  • 15. Albumin and packed red blood cells in the treatment of severely isoimmunised pregnancies.
    Marianowski L; Debski R; Rokicki T; Pasek K; Lukaszewicz E; Gromadzki J
    Mater Med Pol; 1992; 24(4):260-1. PubMed ID: 1308057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management and prevention of red cell alloimmunization in pregnancy: a systematic review.
    Moise KJ; Argoti PS
    Obstet Gynecol; 2012 Nov; 120(5):1132-9. PubMed ID: 23090532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydrops fetalis associated with immunologic and nonimmunologic factors.
    Vintzileos AM; Campbell WA; Deaton JL; Nochimson DJ; Weinbaum PJ
    Am J Perinatol; 1987 Apr; 4(2):115-20. PubMed ID: 3105548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Usefulness of intraperitoneal transfusion under direct ultrasound guidance].
    De la Luna y Olsen E; Amézcua Llauger LE; Leis Marquez MT; Sánchez Solis V
    Ginecol Obstet Mex; 1991 Apr; 59():128-33. PubMed ID: 1908814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of Rh isoimmunization and treatment of the compromised fetus.
    Grannum PA; Copel JA
    Semin Perinatol; 1988 Oct; 12(4):324-35. PubMed ID: 3146812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythroblastosis fetalis produced by anti-k.
    Bowman JM; Harman FA; Manning CR; Pollock JM
    Vox Sang; 1989; 56(3):187-9. PubMed ID: 2728396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.